Decision Makers
Board of Directors
| Organization |
Position |
Status |
| United Therapeutics Corporation |
President and CEO, Duke University Medical Center & Health System |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Founder, Chairman and Chief Executive Officer |
Current |
| Kurzweil Technologies, Inc. |
Chief Executive Officer |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| Kurzweil Technologies, Inc. |
Board of Directors |
Current |
| Inforte Corp |
Board of Directors |
Current |
| The Singularity Institute Co |
Director |
Current |
| The Singularity Challenge |
Director |
Current |
| Kurzweil Technologies, Inc. |
Owner |
Former |
Dr. Jeffs joined United Therapeutics in September 1998 as Director of Research, Development and Medical. Dr. Jeffs was promoted to Vice President of Research, Development and Medical in July 2000, and to President and Chief Operating Officer in January 2001. From 1995 to 1998, Dr. Jeffs worked at Amgen, Inc. where he served as the worldwide clinical leader of the Infectious Disease Program. Dr. Jeffs currently leads the clinical development, commercial and business development efforts at United Therapeutics. He has served as a United Therapeutics director since 2002, and his current term expires in 2011.
| Organization |
Position |
Status |
| United Therapeutics Corporation |
President, Chief Operating Officer and Director |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Executive Vice President and Chief Operating Officer, Production |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Cfo |
Current |
| United Therapeutics Corporation |
Executive Vice President, Business Dev |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Chief Financial Officer and Treasurer |
Current |
| United Therapeutics Corporation |
Treasurer & Vice President |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Chief Information Officer |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Executive Vice President, Strategic Planning, General Counsel |
Current |
| United Therapeutics Corporation |
Vice President |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Deputy General Counsel & Senior Vice President, IR |
Current |
| United Therapeutics Corporation |
Deputy General Counsel & Vice President, IR |
Former |
| Organization |
Position |
Status |
| Core Concepts, Incorporated |
Founder |
Current |
| United Therapeutics Corporation |
Managing Partner, Core Concepts, Llc |
Current |
| United Therapeutics Corporation |
Chairman, Audit Committee, Member, Compensation Committee |
Current |
| Redbranch Technologies, Inc. |
Chairman of the Board |
Current |
| Critical Solutions, Inc. |
Chairman of The Board |
Current |
| United Therapeutics Corporation |
Director |
Current |
| Elevated Security |
Director |
Current |
| Core Concepts, Incorporated |
Managing Member |
Current |
| Power 3 Medical Products, Inc. |
Chief Financial Officer |
Former |
| The Tenth Gate |
Co-Founder |
Former |
| Virginia Business |
Chairman, Red Branch Technologies Inc. |
Former |
| Earth Search Sciences, Inc. |
Director |
Former |
| The Tenth Gate |
Director |
Former |
| Power 3 Medical Products, Inc. |
Director |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Vice Chairman, Lead Director, Chairman, Nominating and Governance Committee, Member, Audit Committee |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| District of Columbia, LLC |
Member |
Current |
| Massachusetts Appeals Court |
Clerk |
Former |
| United Therapeutics Corporation |
Principal Accountant Fees and Services |
Former |
| Harvard Law School |
Jd |
Former |
| Northwestern University |
BA |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Director, University of Oxford Glycobiology Institute, Chairman of the Department of Biochemistry |
Current |
| United Therapeutics Corporation |
Co-Principal Investigator |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| The Royal Society |
Fellow |
Current |
| University of Oxford |
Head of the Department |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Professor and Director, Division of Cardiovascular Disease |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Principal |
Current |
| United Therapeutics Corporation |
Chairman, Compensation Committee, Member, Audit Committee |
Current |
| United Therapeutics Corporation |
Director |
Current |
| Definity Health Corporation |
Chief Marketing Officer |
Former |
| Allina Hospitals & Clinics |
Vice President for Marketing |
Former |
| Directag.Com |
Vice President for Marketing |
Former |
| Blue Shield LLC |
Director of Marketing and Account Management |
Former |
| Causey Consortium |
Principal |
Former |
Ms. Stagg-Hope is a Senior Regulatory Coordinator at United Therapeutics Corporation in Research Triangle Park, NC. She holds expertise in the areas of biotechnology information, FDA regulations and guidances, and agency submissions for regulatory affairs. She has extensive experience in electronic submissions including eCTD, electronic signatures,and assisting companies with compliancy for submissions, assessments, template designs, systems validations, and agency contacts for all countries.
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Senior Regulatory Coordinator |
Current |
| Eli Lilly and Company |
Engineer |
Current |
| Inovatrics Technologies, LLC |
Fda Advisor |
Current |
| Inovatrics Technologies, LLC |
Board of Directors |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
|
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
|
Current |
Baruch S. Blumberg, M.D., Ph.D. , is a Distinguished Scientist at Fox Chase Cancer Center, Philadelphia, and Professor of Medicine and Anthropology at the University of Pennsylvania. Dr. Blumberg's research has covered many areas including clinical research, epidemiology, virology, genetics and anthropology. Dr. Blumberg was awarded the Nobel Prize in 1976 for his work on infectious disease, specifically for the discovery of the Hepatitis B virus, and has also been elected to the National Inventors Hall of Fame for similar work. Dr. Blumberg's research and insight into infectious diseases has been extremely valuable to Maxygen's programs related to vaccines and Hepatitis B in particular.
| Organization |
Position |
Status |
| Fox Chase Cancer Center |
Distinguished Scientist |
Current |
| Meta-Library |
|
Current |
| United Therapeutics Corporation |
Chairman of the Scientific Advisory Board |
Current |
| Maxygen, Inc. |
Board of Directors |
Current |
| The Rockefeller University |
Professor Emeritus |
Former |
| Stanford University |
professor of genetics |
Former |
| Stanford University School of Medicine |
active Professor Emeritus |
Former |
| University of Pennsylvania |
Professor of Medicine and Anthropology |
Former |
| University of Oxford |
Doctorate In Biochemistry |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Committee Chair for Audit Committee |
Current |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Board of Directors |
Current |
Louis Sullivan served as U.S. Secretary of Health and Human Services from 1989 to 1993. Prior to and following his service as HHS Secretary, he was President of Morehouse School of Medicine, which he now serves as President Emeritus. He is co-chair of The Presidential Advisory Council on HIV/AIDS. A graduate of Morehouse College, he earned his medical degree from Boston University, and is certified in internal medicine and hematology. The recipient of 45 honorary degrees, he served on the faculties of the medical schools at Harvard, Seton Hall, and Boston universities before arriving at Morehouse in 1975. He was also the founding president of the Association of Minority Health Professions Schools.
| Organization |
Position |
Status |
| The National Health Museum, Inc |
U.S. Secretary of Health and Human Services |
Current |
| Caligor, Inc. |
Secretary |
Current |
| Biosante Pharmaceuticals, Inc. |
Board of Directors |
Current |
| McDonald's Corporation |
|
Current |
| Go Active |
|
Current |
| Protect The Truth |
|
Current |
| National Families In Action |
|
Current |
| Biosante Pharmaceuticals, Inc. |
Chair of Board |
Current |
| United Therapeutics Corporation |
Board of Directors |
Current |
| Jonas Center for Nursing Excellence |
Board of Directors |
Current |
| Consumer Health Services, Inc. |
Board of Directors |
Current |
| Emergent BioSolutions Inc. |
Director |
Current |
| The National Health Museum, Inc |
Board of Directors |
Current |
| Minority Health |
Board of Directors |
Current |
| Phi Beta Kappa |
Board of Directors |
Current |
| Henry Schein, Inc. |
Board of Directors |
Current |
| Inhibitex, Inc. |
Board of Directors |
Current |
| Antex Biologics, Inc. |
Director |
Current |
| Bristol-Myers Squibb Company |
Board of Directors |
Current |
| Georgia-Pacific Corporation |
Board of Directors |
Current |
| Boyscouts.Com |
Board of Directors |
Current |
| Inhibitex, Inc. |
Member |
Current |
| 3M Company |
President |
Former |
| More House |
President |
Former |
| Boston City Hospital |
Founder |
Former |
| Medical Education |
Founder |
Former |
| Morehouse College |
Director of The Medical Education Program |
Former |
| Morehouse College |
Dean |
Former |
| Harvard Medical School |
Instructor |
Former |
| Morehouse School of Medicine |
Trustee |
Former |
| Morehouse School of Medicine |
President |
Former |
| Harvard Corporation |
|
Former |
| Equifax Inc. |
Board of Directors |
Former |
| 3M Company |
Board of Directors |
Former |
| CIGNA Corporation |
Board of Directors |
Former |
| Human Services Inc |
Secretary |
Former |
| Health-Corp |
Secretary |
Former |
| Care and Company |
Board of Directors |
Former |
| Caligor, Inc. |
Secretary |
Former |
| Ethics Resource Center |
Board of Directors |
Former |
| Boston University |
M.D. |
Former |
| Morehouse College |
B.S. |
Former |
| Boston University |
Medical Degree |
Former |
| Boston University School of Medicine |
Degree |
Former |
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Board of Directors |
Current |
Mr. Giltner has over twenty years of experience in the financial sector. His areas of expertise include international financial markets, financial derivatives, alternative investments and asset management. Prior to beginning a one-year sabbatical on October 15, 2008, Mr. Giltner served as a managing director of Societe Generale Asset Management and head of the European office for its fund of hedge funds group, a position he has held since 2006. From 2003 to 2006, Mr. Giltner was the global head of foreign exchange options for the investment banking arm of Societe Generale. He has also held various other managerial positions with Societe Generale since joining the company in 1991. Mr. Giltner was appointed to the Board of Directors on April 29, 2009, and his current term expires in 2010.
| Organization |
Position |
Status |
| United Therapeutics Corporation |
Board of Directors |
Current |
Executive News
-
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
NewsBlaze - 8/29/09 - View Story
-
Assistant Secretary Duckworth Honored With Women of Distinction Award
PR Newswire - 6/05/09 - View Story
-
Local Drugmaker Found Great Partner in Eli Lilly
Washington Post - 5/31/09 - View Story
-
Fighting an Incurable Disease
Motley Fool - 5/28/09 - View Story
-
UPDATE 4-United Therapeutics gets FDA nod for oral PAH drug
Forbes.com - 5/26/09 - View Story
-
UPDATE 3-United Therapeutics gets FDA nod for oral PAH drug
Forbes.com - 5/26/09 - View Story
-
UPDATE 3-United Therapeutics gets FDA nod for oral PAH drug
Reuters - 5/26/09 - View Story
-
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
PR Newswire - 5/26/09 - View Story
-
Critical Solutions, Inc. Announces New Management Team and New Corporate Location
TradingMarkets - 5/15/09 - View Story
-
Critical Solutions, Inc. Announces New Management Team and New Corporate Location
Street Insider - 5/15/09 - View Story
-
Critical Solutions, Inc. Announces New Management Team and New Corporate Location
Stockwatch - 5/15/09 - View Story